Source: Wall Street News Author: Yuan Wei
Drucken Miller's stock portfolio performed strongly in the last quarter, and the total market value of his holdings increased by more than 20% to nearly $3.4 billion.
The latest positions of the world's top family offices have been revealed.
According to the latest 13F documents submitted this Wednesday, the family office of former Soros deputy and billionaire Stanley Druckenmiller has been sold$Alphabet-A (GOOGL.US)$,$Amazon (AMZN.US)$und$Broadcom (AVGO.US)$Shares were bought at the same time as gold miners that were hit hard$Barrick Gold (GOLD.US)$und$Newmont (NEM.US)$The stock.
As of December 31, 2023, artificial intelligence remains a prominent theme in Drucken Miller's portfolio, according to the document. The family office not only bought an artificial intelligence-related company$Adobe (ADBE.US)$und$Arista Networks (ANET.US)$Of the shares, 64,715 shares were also purchased$Palo Alto Networks (PANW.US)$The stock.
It is worth mentioning that$NVIDIA (NVDA.US)$It is Drucken Miller's largest holding. His fund holds Nvidia shares worth nearly $550 million, accounting for about 16% of its total share capital.
At the beginning of last year, Drucken Miller viewed Nvidia as an investment opportunity in the field of artificial intelligence, but later said in the fall that the stock was already “overheated.” Since then, Nvidia's stock price has almost doubled. Since the beginning of 2024 alone, Nvidia shares have risen by nearly 50%, according to FactSet.
Drucken Miller became famous for his collaboration with George Soros, and his company stopped accepting funding from outside investors more than a decade ago. However, his views on the market are still sought after by financial media, professional investors, and amateurs.
Drucken Miller's decision to sell Google shares drew attention because he just bought the stock in the third quarter of 2023.
In addition, he has sold around 50,000 shares$Eli Lilly and Co (LLY.US)$stocks. According to FactSet, over the past few months, Eli Lilly has been ranked in the top 10 most valuable companies in the S&P 500 Index due to the popularity of its weight loss and diabetes medications Zepbound and Mounjaro.
Overall, Drucken Miller's stock portfolio was strong in the last quarter, and the total market value of his holdings increased by more than 20% to nearly $3.4 billion.
edit/lambor